Diaphorina citri psyllid: psy8083

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300---
MLAKHLARQKKCKIEARRPGLSVLLCSPRQGTNVDENSAFIGDLPLLKRVSAPSDVFCSVPGRLSLLSSTSKYKVTVGEVQRRLSPPECLNASLLGGVLRRAKSKNGGRLLREKLEKIGLNLPAGRRKAANVTLLTSLVEGEAIHLARDFGYVCETEFPARQVAEYLSRQHTSDPTESYRRKELIHATKQVTKELMDLLNQDRSPLCNTRPQHILDPSIQRHLTHFSLISHGFGSPAIVAALTAIQNFLTESLKHLDKMYPSGNSLSVSSSQGLQDTKPKDLGNDLKNIWPCQGHAGSKSKTI
cHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEECcccccccccccccEEEEEEEcccccccccccccccHHHHHHccccccHHHHHHHHHHHcccccccccccccccEEEEEcHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccc
*******************GLSVLLCSPR************GDLPLLKRVSAPSDVFCSVPGRLSLLSSTSKYKVTVGEVQRRLSPPECLNASLLGGVLRRAK****GRLLREKLEKIGLNLPAGRRKAANVTLLTSLVEGEAIHLARDFGYVCETEFPARQVAEYLSRQHTSDPTESYRRKELIHATKQVTKELMDLLNQD***LCNTRPQHILDPSIQRHLTHFSLISHGFGSPAIVAALTAIQNFLTESLKHL***********************************************
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MLAKHLARQKKCKIEARRPGLSVLLCSPRQGTNVDENSAFIGDLPLLKRVSAPSDVFCSVPGRLSLLSSTSKYKVTVGEVQRRLSPPECLNASLLGGVLRRAKSKNGGRLLREKLEKIGLNLPAGRRKAANVTLLTSLVEGEAIHLARDFGYVCETEFPARQVAEYLSRQHTSDPTESYRRKELIHATKQVTKELMDLLNQDRSPLCNTRPQHILDPSIQRHLTHFSLISHGFGSPAIVAALTAIQNFLTESLKHLDKMYPSGNSLSVSSSQGLQDTKPKDLGNDLKNIWPCQGHAGSKSKTI

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Transcription factor AP-2-alpha Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter transcription activation. Associates with chromatin to the PITX2 P1 promoter region.confidentP34056
Transcription factor AP-2-alpha Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter transcription activation. Associates with chromatin to the PITX2 P1 promoter region.confidentP05549
Transcription factor AP-2-alpha Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter transcription activation. Associates with chromatin to the PITX2 P1 promoter region.confidentA1A4R9

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0000977 [MF]RNA polymerase II regulatory region sequence-specific DNA bindingconfidentGO:0043565, GO:0044212, GO:0001067, GO:0003677, GO:0001012, GO:0000976, GO:0005488, GO:0003676, GO:0000975, GO:0003674, GO:0097159, GO:1901363
GO:0001158 [MF]enhancer sequence-specific DNA bindingconfidentGO:0044212, GO:0043565, GO:0097159, GO:0003677, GO:0001067, GO:0000976, GO:0035326, GO:0003676, GO:0000975, GO:0003674, GO:1901363, GO:0005488
GO:0046983 [MF]protein dimerization activityconfidentGO:0003674, GO:0005488, GO:0005515
GO:0003714 [MF]transcription corepressor activityconfidentGO:0003674, GO:0003712, GO:0000989, GO:0000988
GO:0005730 [CC]nucleolusconfidentGO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0005813 [CC]centrosomeconfidentGO:0005856, GO:0005575, GO:0015630, GO:0043232, GO:0044464, GO:0005623, GO:0005815, GO:0044446, GO:0043229, GO:0043228, GO:0044430, GO:0044424, GO:0005622, GO:0043226, GO:0044422
GO:0003713 [MF]transcription coactivator activityconfidentGO:0003674, GO:0003712, GO:0000989, GO:0000988
GO:0005794 [CC]Golgi apparatusconfidentGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0000981 [MF]sequence-specific DNA binding RNA polymerase II transcription factor activityconfidentGO:0003700, GO:0003674, GO:0001071
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterconfidentGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0014032 [BP]neural crest cell developmentprobableGO:0030154, GO:0048468, GO:0007275, GO:0044699, GO:0014033, GO:0014031, GO:0048864, GO:0048869, GO:0048513, GO:0032502, GO:0048762, GO:0032501, GO:0009987, GO:0009888, GO:0044767, GO:0048863, GO:0044763, GO:0048731, GO:0060485, GO:0044707, GO:0048856, GO:0008150
GO:2000378 [BP]negative regulation of reactive oxygen species metabolic processprobableGO:0009892, GO:0019222, GO:0031324, GO:0031323, GO:2000377, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0003334 [BP]keratinocyte developmentprobableGO:0030154, GO:0048468, GO:0008544, GO:0007275, GO:0044699, GO:0048869, GO:0048513, GO:0030855, GO:0002064, GO:0032502, GO:0032501, GO:0030216, GO:0060429, GO:0009888, GO:0044767, GO:0008150, GO:0048731, GO:0044707, GO:0009913, GO:0048856, GO:0044763, GO:0009987
GO:0000978 [MF]RNA polymerase II core promoter proximal region sequence-specific DNA bindingprobableGO:0044212, GO:0043565, GO:0001067, GO:0003677, GO:0001012, GO:0001159, GO:0000976, GO:0000977, GO:0003676, GO:0000975, GO:0000987, GO:0003674, GO:0097159, GO:1901363, GO:0005488
GO:0000979 [MF]RNA polymerase II core promoter sequence-specific DNA bindingprobableGO:0044212, GO:0003676, GO:0043565, GO:0001067, GO:0000975, GO:0001012, GO:0000976, GO:0000977, GO:0001047, GO:0001046, GO:0003674, GO:0097159, GO:0003677, GO:1901363, GO:0005488
GO:0000122 [BP]negative regulation of transcription from RNA polymerase II promoterprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0008284 [BP]positive regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0008285 [BP]negative regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0043066 [BP]negative regulation of apoptotic processprobableGO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0032496 [BP]response to lipopolysaccharideprobableGO:1901700, GO:0009607, GO:0033993, GO:0050896, GO:0009617, GO:0008150, GO:0002237, GO:0042221, GO:0051707, GO:0010033, GO:0051704
GO:0043525 [BP]positive regulation of neuron apoptotic processprobableGO:0050789, GO:0050794, GO:0043065, GO:0010942, GO:0043067, GO:0043523, GO:0065007, GO:0048518, GO:1901216, GO:0008150, GO:1901214, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0071281 [BP]cellular response to iron ionprobableGO:0051716, GO:0071248, GO:0010038, GO:0050896, GO:0009987, GO:0071241, GO:0008150, GO:0044763, GO:0070887, GO:0010039, GO:0042221, GO:0010035, GO:0044699
GO:0005829 [CC]cytosolprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0006366 [BP]transcription from RNA polymerase II promoterprobableGO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006351, GO:0019438
GO:0050796 [BP]regulation of insulin secretionprobableGO:0090087, GO:0032879, GO:0060341, GO:0051046, GO:0002791, GO:0050794, GO:0008150, GO:0090276, GO:0046883, GO:0051049, GO:0023051, GO:0065007, GO:0010646, GO:0050789
GO:0046982 [MF]protein heterodimerization activityprobableGO:0046983, GO:0003674, GO:0005488, GO:0005515
GO:0070172 [BP]positive regulation of tooth mineralizationprobableGO:0070169, GO:0051094, GO:0050793, GO:0070170, GO:0051240, GO:0022603, GO:0070167, GO:0008150, GO:2000026, GO:2000027, GO:0051239, GO:0042481, GO:0048518, GO:0065007, GO:0050789
GO:0043588 [BP]skin developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0009888, GO:0048513, GO:0008150, GO:0048731, GO:0008544, GO:0007275, GO:0044699
GO:0001105 [MF]RNA polymerase II transcription coactivator activityprobableGO:0001190, GO:0003713, GO:0003712, GO:0001104, GO:0001076, GO:0003674, GO:0000989, GO:0000988
GO:0030501 [BP]positive regulation of bone mineralizationprobableGO:0070169, GO:0045778, GO:0050793, GO:0051240, GO:0051094, GO:0070167, GO:0008150, GO:0048518, GO:2000026, GO:0051239, GO:0030500, GO:0065007, GO:0030278, GO:0050789
GO:0001078 [MF]RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcriptionprobableGO:0001227, GO:0003700, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0010842 [BP]retina layer formationprobableGO:0032502, GO:0032501, GO:0044699, GO:0048856, GO:0044707, GO:0007423, GO:0001654, GO:0048592, GO:0048593, GO:0009887, GO:0044767, GO:0048513, GO:0003407, GO:0060041, GO:0060042, GO:0048731, GO:0008150, GO:0009653, GO:0043010, GO:0007275, GO:0048646
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0006006 [BP]glucose metabolic processprobableGO:0044238, GO:0005975, GO:0005996, GO:0019318, GO:0071704, GO:0008150, GO:0008152, GO:0044723
GO:0001077 [MF]RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcriptionprobableGO:0003700, GO:0001228, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0005667 [CC]transcription factor complexprobableGO:0043234, GO:0044446, GO:0032991, GO:0005575, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0048485 [BP]sympathetic nervous system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0007399, GO:0048856, GO:0008150, GO:0048483, GO:0048731, GO:0007275, GO:0044699
GO:0000983 [MF]RNA polymerase II core promoter sequence-specific DNA binding transcription factor activityprobableGO:0003700, GO:0003674, GO:0001071, GO:0000981
GO:0000980 [MF]RNA polymerase II distal enhancer sequence-specific DNA bindingprobableGO:0005488, GO:0044212, GO:0043565, GO:0001067, GO:0003677, GO:0001012, GO:0001158, GO:0000976, GO:0000977, GO:0003676, GO:0000975, GO:0003674, GO:0097159, GO:1901363, GO:0035326
GO:0001106 [MF]RNA polymerase II transcription corepressor activityprobableGO:0001191, GO:0003714, GO:0003712, GO:0001104, GO:0001076, GO:0003674, GO:0000989, GO:0000988
GO:0003682 [MF]chromatin bindingprobableGO:0003674, GO:0005488
GO:0061303 [BP]cornea development in camera-type eyeprobableGO:0032502, GO:0032501, GO:0044707, GO:0007423, GO:0048856, GO:0044767, GO:0048513, GO:0001654, GO:0048731, GO:0008150, GO:0043010, GO:0007275, GO:0044699
GO:0014036 [BP]neural crest cell fate specificationprobableGO:0030154, GO:0048468, GO:0009790, GO:0009792, GO:0009653, GO:0007275, GO:0044699, GO:0014033, GO:0000904, GO:0048864, GO:0000902, GO:0014034, GO:0048869, GO:0001708, GO:0016043, GO:0032989, GO:0048513, GO:0071840, GO:0043009, GO:0032502, GO:0048762, GO:0032501, GO:0009987, GO:0009888, GO:0044767, GO:0048863, GO:0008150, GO:0048731, GO:0060485, GO:0014031, GO:0045165, GO:0044707, GO:0014029, GO:0048856, GO:0001837, GO:0044763
GO:0003091 [BP]renal water homeostasisprobableGO:0032501, GO:0050878, GO:0044707, GO:0050891, GO:0048878, GO:0042592, GO:0003014, GO:0008150, GO:0030104, GO:0065007, GO:0065008, GO:0044699, GO:0003008
GO:0050935 [BP]iridophore differentiationprobableGO:0032502, GO:0043473, GO:0009987, GO:0048869, GO:0050931, GO:0030154, GO:0048066, GO:0044763, GO:0008150, GO:0044699
GO:0097277 [BP]cellular urea homeostasisprobableGO:0019725, GO:0009987, GO:0048878, GO:0042592, GO:0065007, GO:0044763, GO:0097274, GO:0008150, GO:0055082, GO:0065008, GO:0044699
GO:0097276 [BP]cellular creatinine homeostasisprobableGO:0019725, GO:0009987, GO:0048878, GO:0042592, GO:0097273, GO:0065007, GO:0044763, GO:0008150, GO:0055082, GO:0065008, GO:0044699
GO:0043027 [MF]cysteine-type endopeptidase inhibitor activity involved in apoptotic processprobableGO:0004866, GO:0030234, GO:0061134, GO:0043028, GO:0003674, GO:0030414, GO:0004869, GO:0004857, GO:0061135
GO:0060788 [BP]ectodermal placode formationprobableGO:0032502, GO:0048856, GO:0044767, GO:0008150, GO:0044699, GO:0009653, GO:0071697, GO:0071696, GO:0048646
GO:0003151 [BP]outflow tract morphogenesisprobableGO:0032502, GO:0044767, GO:0009887, GO:0032501, GO:0044707, GO:0007507, GO:0048513, GO:0048856, GO:0003007, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0048701 [BP]embryonic cranial skeleton morphogenesisprobableGO:0048598, GO:0048562, GO:0048568, GO:0009790, GO:0048706, GO:0009653, GO:0007275, GO:0044699, GO:0048513, GO:0043009, GO:0048705, GO:0048704, GO:0009887, GO:0032501, GO:0044767, GO:0008150, GO:0044707, GO:0001501, GO:0048856, GO:0032502, GO:0009792, GO:0048731
GO:0035019 [BP]somatic stem cell maintenanceprobableGO:0030154, GO:0048468, GO:0050789, GO:0044699, GO:0048863, GO:0048864, GO:0048869, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0044767, GO:0045596, GO:0045595, GO:0008150, GO:0051093, GO:0019827, GO:0044707, GO:0048856, GO:0044763, GO:0048523
GO:0009414 [BP]response to water deprivationprobableGO:1901700, GO:0009628, GO:0050896, GO:0006950, GO:0008150, GO:0009415, GO:0042221, GO:0010035
GO:0010226 [BP]response to lithium ionprobableGO:0042221, GO:0050896, GO:0010035, GO:0008150, GO:0010038
GO:0030318 [BP]melanocyte differentiationprobableGO:0032502, GO:0043473, GO:0060429, GO:0048856, GO:0048869, GO:0050931, GO:0030154, GO:0009888, GO:0048066, GO:0044763, GO:0030855, GO:0060563, GO:0008150, GO:0009987, GO:0044699, GO:0002065
GO:0010172 [BP]embryonic body morphogenesisprobableGO:0048598, GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0008150, GO:0010171, GO:0009653, GO:0007275, GO:0044699
GO:0042593 [BP]glucose homeostasisprobableGO:0033500, GO:0048878, GO:0042592, GO:0008150, GO:0065007, GO:0065008
GO:0060349 [BP]bone morphogenesisprobableGO:0048705, GO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0048856, GO:0060348, GO:0044767, GO:0001501, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0060021 [BP]palate developmentprobableGO:0032502, GO:0048856, GO:0008150
GO:0045444 [BP]fat cell differentiationprobableGO:0032502, GO:0030154, GO:0048869, GO:0009987, GO:0044763, GO:0008150, GO:0044699
GO:0045664 [BP]regulation of neuron differentiationprobableGO:0030154, GO:0007275, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0050789, GO:0008150, GO:0065007, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0044763, GO:0051239, GO:0022008, GO:0048699, GO:0007399, GO:0044707, GO:0048856, GO:0051960, GO:2000026, GO:0048731
GO:0097070 [BP]ductus arteriosus closureprobableGO:0032502, GO:0032501, GO:0044707, GO:0048844, GO:0048856, GO:0001944, GO:0007275, GO:0044767, GO:0072359, GO:0072358, GO:0048514, GO:0008150, GO:0048731, GO:0009653, GO:0060840, GO:0001568, GO:0044699
GO:0021506 [BP]anterior neuropore closureprobableGO:0032502, GO:0016331, GO:0035148, GO:0009790, GO:0072175, GO:0009792, GO:0035239, GO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0048729, GO:0001841, GO:0060562, GO:0001843, GO:0048646, GO:0048598, GO:0032501, GO:0021915, GO:0060429, GO:0009888, GO:0060606, GO:0008150, GO:0035295, GO:0021995, GO:0043009, GO:0001838, GO:0014020, GO:0007399, GO:0044707, GO:0048856, GO:0044767, GO:0048731
GO:0097275 [BP]cellular ammonia homeostasisprobableGO:0019725, GO:0065007, GO:0009987, GO:0048878, GO:0042592, GO:0097272, GO:0044763, GO:0008150, GO:0055082, GO:0065008, GO:0044699
GO:0009880 [BP]embryonic pattern specificationprobableGO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0008150, GO:0007275, GO:0044699
GO:0060235 [BP]lens induction in camera-type eyeprobableGO:0030154, GO:0032501, GO:0023052, GO:0002088, GO:0002089, GO:0009653, GO:0007275, GO:0044699, GO:0048869, GO:0008150, GO:0048513, GO:0032502, GO:0009887, GO:0009987, GO:0031128, GO:0048592, GO:0048593, GO:0044767, GO:0044763, GO:0048731, GO:0007267, GO:0007154, GO:0044700, GO:0045165, GO:0044707, GO:0007423, GO:0048856, GO:0045168, GO:0001654, GO:0043010
GO:0043154 [BP]negative regulation of cysteine-type endopeptidase activity involved in apoptotic processprobableGO:0019222, GO:0007569, GO:0010941, GO:0042981, GO:0050789, GO:0044699, GO:0051346, GO:2000116, GO:2000117, GO:0043086, GO:0043067, GO:0010466, GO:0065007, GO:0044092, GO:0043281, GO:0065009, GO:0010259, GO:0006915, GO:0052547, GO:0052548, GO:0009987, GO:0050794, GO:0012501, GO:0044763, GO:0010951, GO:0051336, GO:0050790, GO:0008150
GO:0001942 [BP]hair follicle developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0022405, GO:0009888, GO:0022404, GO:0048513, GO:0008150, GO:0042633, GO:0048731, GO:0008544, GO:0042303, GO:0007275, GO:0044699
GO:0021884 [BP]forebrain neuron developmentprobableGO:0032502, GO:0044707, GO:0030154, GO:0048468, GO:0007275, GO:0044699, GO:0007417, GO:0048869, GO:0008150, GO:0048513, GO:0021879, GO:0021954, GO:0021872, GO:0021953, GO:0048666, GO:0032501, GO:0030182, GO:0009987, GO:0044767, GO:0044763, GO:0022008, GO:0048699, GO:0007420, GO:0007399, GO:0048856, GO:0030900, GO:0048731
GO:0021559 [BP]trigeminal nerve developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0007399, GO:0048856, GO:0048731, GO:0044767, GO:0008150, GO:0021545, GO:0021675, GO:0007275, GO:0044699
GO:0060750 [BP]epithelial cell proliferation involved in mammary gland duct elongationprobableGO:0048589, GO:0033598, GO:0001763, GO:0009653, GO:0060751, GO:0044699, GO:0002009, GO:0040007, GO:0061138, GO:0007275, GO:0060443, GO:0060444, GO:0048729, GO:0060562, GO:0060560, GO:0030879, GO:0032502, GO:0032501, GO:0035239, GO:0008283, GO:0060429, GO:0009888, GO:0048731, GO:0044767, GO:0060602, GO:0048754, GO:0022612, GO:0035295, GO:0048513, GO:0044707, GO:0048856, GO:0050673, GO:0003401, GO:0008150, GO:0048732, GO:0061180, GO:0060603
GO:0072017 [BP]distal tubule developmentprobableGO:0032502, GO:0048513, GO:0009888, GO:0048856, GO:0061326, GO:0044707, GO:0072073, GO:0032501, GO:0060429, GO:0001822, GO:0072006, GO:0044767, GO:0072009, GO:0072080, GO:0008150, GO:0001655, GO:0007275, GO:0048731, GO:0035295, GO:0072001, GO:0044699
GO:0007485 [BP]imaginal disc-derived male genitalia developmentprobableGO:0032502, GO:0035215, GO:0007484, GO:0048608, GO:0000003, GO:0044707, GO:0007444, GO:0061458, GO:0032501, GO:0048856, GO:0022414, GO:0007548, GO:0044767, GO:0003006, GO:0048513, GO:0048806, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0008134 [MF]transcription factor bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0030718 [BP]germ-line stem cell maintenanceprobableGO:0030154, GO:0048468, GO:0050789, GO:0044699, GO:0048863, GO:0048864, GO:0048869, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0044767, GO:0045596, GO:0045595, GO:0008150, GO:0051093, GO:0019827, GO:0044707, GO:0048856, GO:0044763, GO:0048523
GO:0042493 [BP]response to drugprobableGO:0042221, GO:0050896, GO:0008150
GO:0071711 [BP]basement membrane organizationprobableGO:0009987, GO:0016043, GO:0030198, GO:0044763, GO:0071840, GO:0043062, GO:0008150, GO:0044699
GO:0048730 [BP]epidermis morphogenesisprobableGO:0032502, GO:0009887, GO:0008544, GO:0044707, GO:0032501, GO:0048856, GO:0009888, GO:0044767, GO:0048513, GO:0008150, GO:0048729, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0048733 [BP]sebaceous gland developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0048732, GO:0007275, GO:0044699
GO:0035115 [BP]embryonic forelimb morphogenesisprobableGO:0048598, GO:0032502, GO:0035108, GO:0044707, GO:0030326, GO:0060173, GO:0035107, GO:0044767, GO:0009790, GO:0032501, GO:0035136, GO:0044699, GO:0035113, GO:0008150, GO:0009653, GO:0007275, GO:0048736, GO:0048856
GO:0060325 [BP]face morphogenesisprobableGO:0032502, GO:0048856, GO:0044767, GO:0060323, GO:0060322, GO:0008150, GO:0060324, GO:0010171, GO:0009653, GO:0044699
GO:0010960 [BP]magnesium ion homeostasisprobableGO:0072507, GO:0050801, GO:0048878, GO:0042592, GO:0065007, GO:0055065, GO:0055080, GO:0008150, GO:0065008
GO:0001829 [BP]trophectodermal cell differentiationprobableGO:0032502, GO:0032501, GO:0001824, GO:0044707, GO:0009987, GO:0048869, GO:0001825, GO:0030154, GO:0044767, GO:0009790, GO:0001701, GO:0044763, GO:0048646, GO:0009792, GO:0008150, GO:0043009, GO:0009653, GO:0007275, GO:0044699, GO:0048856
GO:0007605 [BP]sensory perception of soundprobableGO:0032501, GO:0044707, GO:0050954, GO:0007600, GO:0008150, GO:0050877, GO:0044699, GO:0003008
GO:0060598 [BP]dichotomous subdivision of terminal units involved in mammary gland duct morphogenesisprobableGO:0048754, GO:0001763, GO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0060443, GO:0060444, GO:0048729, GO:0022612, GO:0030879, GO:0032502, GO:0032501, GO:0035239, GO:0061138, GO:0060429, GO:0009888, GO:0044767, GO:0008150, GO:0060603, GO:0060600, GO:0060562, GO:0035295, GO:0048513, GO:0044707, GO:0048856, GO:0048731, GO:0048732, GO:0061180
GO:0042059 [BP]negative regulation of epidermal growth factor receptor signaling pathwayprobableGO:0010646, GO:0009968, GO:0050794, GO:0009966, GO:0048585, GO:0048583, GO:0042058, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:1901184, GO:1901185, GO:0050789, GO:0048523
GO:0021987 [BP]cerebral cortex developmentprobableGO:0021537, GO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0021543, GO:0048513, GO:0030900, GO:0048731, GO:0008150, GO:0007275, GO:0044699, GO:0007417
GO:0048728 [BP]proboscis developmentprobableGO:0032502, GO:0032501, GO:0035213, GO:0044707, GO:0007444, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0035810 [BP]positive regulation of urine volumeprobableGO:0032501, GO:0050878, GO:0044707, GO:0008150, GO:0035809, GO:0003014, GO:0065007, GO:0065008, GO:0044699, GO:0003008
GO:0030335 [BP]positive regulation of cell migrationprobableGO:0051272, GO:0030334, GO:0040017, GO:0040012, GO:0008150, GO:0051270, GO:2000145, GO:2000147, GO:0048518, GO:0065007, GO:0032879, GO:0050794, GO:0050789, GO:0048522
GO:0016348 [BP]imaginal disc-derived leg joint morphogenesisprobableGO:0048563, GO:0035108, GO:0048569, GO:0060173, GO:0035107, GO:0009887, GO:0009791, GO:0035120, GO:0002165, GO:0032501, GO:0035127, GO:0035282, GO:0009653, GO:0007275, GO:0044699, GO:0007389, GO:0007478, GO:0036022, GO:0035285, GO:0048513, GO:0048646, GO:0032502, GO:0048707, GO:0009886, GO:0007480, GO:0035218, GO:0044767, GO:0008150, GO:0003002, GO:0048731, GO:0035114, GO:0044707, GO:0007444, GO:0048856, GO:0007560, GO:0036011, GO:0007552, GO:0048736, GO:0048737
GO:0035909 [BP]aorta morphogenesisprobableGO:0032502, GO:0032501, GO:0044707, GO:0048844, GO:0048856, GO:0001944, GO:0007275, GO:0044767, GO:0072359, GO:0072358, GO:0048514, GO:0008150, GO:0035904, GO:0048731, GO:0009653, GO:0060840, GO:0001568, GO:0044699
GO:0030902 [BP]hindbrain developmentprobableGO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0008584 [BP]male gonad developmentprobableGO:0032502, GO:0022414, GO:0007548, GO:0032501, GO:0048608, GO:0000003, GO:0044707, GO:0046546, GO:0061458, GO:0048856, GO:0008406, GO:0045137, GO:0007275, GO:0044767, GO:0003006, GO:0048513, GO:0008150, GO:0048731, GO:0046661, GO:0044699
GO:0055075 [BP]potassium ion homeostasisprobableGO:0050801, GO:0048878, GO:0042592, GO:0065007, GO:0055067, GO:0055065, GO:0055080, GO:0008150, GO:0065008
GO:0055074 [BP]calcium ion homeostasisprobableGO:0072507, GO:0050801, GO:0048878, GO:0042592, GO:0065007, GO:0055065, GO:0055080, GO:0008150, GO:0065008
GO:0055078 [BP]sodium ion homeostasisprobableGO:0050801, GO:0048878, GO:0042592, GO:0065007, GO:0055067, GO:0055065, GO:0055080, GO:0008150, GO:0065008
GO:0061029 [BP]eyelid development in camera-type eyeprobableGO:0032502, GO:0032501, GO:0044707, GO:0007423, GO:0048856, GO:0044767, GO:0048513, GO:0001654, GO:0048731, GO:0008150, GO:0043010, GO:0007275, GO:0044699
GO:0072044 [BP]collecting duct developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0001822, GO:0044767, GO:0048513, GO:0008150, GO:0001655, GO:0048731, GO:0072001, GO:0007275, GO:0044699
GO:0030510 [BP]regulation of BMP signaling pathwayprobableGO:0090092, GO:0009966, GO:0048583, GO:0050794, GO:0065007, GO:0023051, GO:0008150, GO:0010646, GO:0050789
GO:0051216 [BP]cartilage developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0009888, GO:0061448, GO:0001501, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0003404 [BP]optic vesicle morphogenesisprobableGO:0032502, GO:0048562, GO:0048568, GO:0031076, GO:0009790, GO:0009653, GO:0007275, GO:0044699, GO:0008150, GO:0048513, GO:0048048, GO:0048598, GO:0009887, GO:0032501, GO:0048592, GO:0048593, GO:0048596, GO:0044767, GO:0001654, GO:0007423, GO:0044707, GO:0048856, GO:0048731, GO:0043010
GO:0003409 [BP]optic cup structural organizationprobableGO:0032502, GO:0016331, GO:0048562, GO:0048568, GO:0031076, GO:0009790, GO:0032501, GO:0009653, GO:0007275, GO:0048048, GO:0002009, GO:0048513, GO:0044699, GO:0048729, GO:0048532, GO:0048646, GO:0048598, GO:0009887, GO:0048593, GO:0048592, GO:0060429, GO:0009888, GO:0048596, GO:0044767, GO:0008150, GO:0048731, GO:0060900, GO:0007423, GO:0044707, GO:0048856, GO:0001654, GO:0002072, GO:0043010
GO:0021623 [BP]oculomotor nerve formationprobableGO:0021557, GO:0021783, GO:0021622, GO:0048486, GO:0048483, GO:0021603, GO:0021602, GO:0009653, GO:0007275, GO:0044699, GO:0007417, GO:0048646, GO:0032502, GO:0032501, GO:0044767, GO:0008150, GO:0021545, GO:0021675, GO:0007399, GO:0044707, GO:0048856, GO:0048731
GO:0055062 [BP]phosphate ion homeostasisprobableGO:0072506, GO:0050801, GO:0048878, GO:0042592, GO:0065007, GO:0008150, GO:0055081, GO:0065008
GO:0061379 [BP]inferior colliculus developmentprobableGO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0061378, GO:0048731, GO:0007417, GO:0007275, GO:0044699, GO:0030901
GO:0035137 [BP]hindlimb morphogenesisprobableGO:0032502, GO:0035108, GO:0044707, GO:0060173, GO:0035107, GO:0044767, GO:0032501, GO:0008150, GO:0044699, GO:0009653, GO:0007275, GO:0048736, GO:0048856
GO:0072210 [BP]metanephric nephron developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0001822, GO:0007275, GO:0044767, GO:0048513, GO:0008150, GO:0001655, GO:0001656, GO:0048731, GO:0072001, GO:0072006, GO:0044699
GO:0045682 [BP]regulation of epidermis developmentprobableGO:0050793, GO:0008150, GO:0065007, GO:0051239, GO:2000026, GO:0050789
GO:0010944 [BP]negative regulation of transcription by competitive promoter bindingprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0021877 [BP]forebrain neuron fate commitmentprobableGO:0044707, GO:0030154, GO:0007275, GO:0044699, GO:0007417, GO:0048869, GO:0008150, GO:0048513, GO:0021879, GO:0021872, GO:0021953, GO:0032502, GO:0032501, GO:0048663, GO:0030182, GO:0009987, GO:0044767, GO:0044763, GO:0022008, GO:0048699, GO:0045165, GO:0007420, GO:0007399, GO:0048856, GO:0030900, GO:0048731
GO:0014044 [BP]Schwann cell developmentprobableGO:0032502, GO:0048856, GO:0014037, GO:0007399, GO:0007422, GO:0009987, GO:0048869, GO:0030154, GO:0048468, GO:0042063, GO:0021782, GO:0044767, GO:0032501, GO:0044763, GO:0008150, GO:0010001, GO:0048731, GO:0022008, GO:0007275, GO:0044699, GO:0044707
GO:0042472 [BP]inner ear morphogenesisprobableGO:0042471, GO:0048598, GO:0048839, GO:0048562, GO:0044707, GO:0007423, GO:0048568, GO:0032501, GO:0048856, GO:0009887, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0043583, GO:0048731, GO:0009653, GO:0032502, GO:0007275, GO:0044699

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!